BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 14, 2008
View Archived Issues
HSV-2 vaccine dl5-29 effective in HSV-1 seropositive guinea pigs
Read More
Recent patents disclose new anticancer agents
Read More
G-CSF-induced neuroprotection in mouse models of ALS
Read More
Avir commences phase I study for intranasal pandemic influenza vaccine deltaFLU
Read More
Proellex reduces pain in phase II clinical trial in moderate to severe endometriosis
Read More
GlobeImmune collaborates with the NIH to develop cancer therapeutics
Read More
Targeting CaMKK2 may be useful for the treatment of obesity and diabetes
Read More
Novartis enters strategic partnership with Lonza to accelerate its biologics pipeline
Read More
Study shows bioequivalence between Insmed's INS-19 and Neupogen
Read More
Novel analgesic agents described in recent patent literature
Read More
Proteolix initiates dosing in phase Ib clinical trial of proteasome inhibitor carfilzomib
Read More
Promising preclinical results with STF-62247 in treating renal cell carcinoma
Read More
DSMB recommends discontinuation of vaccinations in phase III TRIST study of TroVax
Read More
Recent Exelixis and Nippon Zoki patents report new treatment options for metabolic disorders
Read More
Pharming reports positive results from open-label studies of Rhucin in HAE
Read More
Napo reports results from phase IIa and IIb trials of crofelemer in D-IBS
Read More
NeurogesX initiates phase I clinical trial of NGX-1998 for neuropathic pain
Read More
Nile Therapeutics initiates dosing in phase IIa clinical study of CD-NP in heart failure
Read More
Alcon terminates development of anecortave acetate in AMD
Read More
Actelion and GSK collaborate on almorexant in sleep disorders
Read More
Tredaptive approved in E.U. for dyslipidemia and primary hypercholesterolemia
Read More
